Assessment the Role of Erythrocyte Sedimentation Rate and C-Reactive Protein Tests For Prediction Of Rheumatoid Arthritis Activity In Misan Province

Nader A.  Salman

doi:10.36371/port.2024.special.2

Authors

Nader A. Salman Al-Manara College for Medical Sciences, Missan, Iraq.

Abstract References Downloads Cite Statistics Share Information

Rheumatoid Arthritis (RA) activity was assessed based on erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) tests. The ESR and CRP tests were monitored in 25 Rheumatoid Arthritis diagnosed patients and 25 healthy approved cases of suspected patients from Missan Province. The sample comprised of 25 male and 25 females with ages varied from 21-68 years and body weights from 45 – 112 kg. ESR readings in RA diagnosed patients varied between 22 – 116 averaged 46.8 mm/h in patients case while those recorded in the healthy approvrd cases ranged between 4-18 averaged 8.4 mm/h. Differences between patients and control cases were statistically significant (P < 0.05). This approved that measuring ESR is a valid tool to predict RA among Missan population. CRP test showed only 2 negative results among RA patients compared with 15 negative results in healthy approved cases. CRP values in patients sample ranged between 10 mg/dl in 11 cases and 24 – 48 mg/dl in another 11 cases with only one highly extreme value of 96 mg/dl. In he healthy approved cases, CRP values ranging from 6-12 mg/dl were recorded in 10 cases and negative results in the rest 15 cases. differences were highly significant (p< 0.01) indicating the validity of CRP test to predict RA cases. Both parameters varied among various age groups, gender and body weight classes. Apparantly both ESR and CRP tests may help to find or monitor inflammation in acute or chronic conditions of rheumatoid arthritis.

Keywords:

ESR, CRP, Rheumatoid Arthritis, Missan Province

[1] American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002). Guidelines for the management of rheumatoid arthritis: update. Arthritis Rheum. 2002;46:328-346.

[2] Arnett F.C., Edworthy S.M., Bloch DA, McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan SR, Liang M.H,, Luthra H,S. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum; 31:315–24.

[3] Deighton C, O’Mahoney R, Tosh J, Turner C, Rudolf M (2009). Guideline Development Group. Management of rheumatoid arthritis: summary of NICE guidance. BMJ;338:710–2.

[4] Dessein P.H. , Joffe B.I. , Stanwix A.E. (2004). High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. J Rheumatol, 31 (2004), pp. 1095-1097.

[5] Firestein GS. (2005). Etiology and pathogenesis of rheumatoid arthritis. In: Kelley’s Textbook of Rheumatology, 7th ed. Philadelphia, PA: W.B. Saunders : 996-1042.

[6] Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, et al. (2005). Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis : a randomized, controlled trial. Arthritis Rheum, 52:3381–90.

[7] Harris ED. (2005). Clinical features of rheumatoid arthritis. In: Kelley’s Textbook of Rheumatology, 7th ed. Philadelphia, PA: W.B. Saunders; 1043-1078.

[8] Keenan R.T, Swearingen C.J, Yazici Y (2008): Erythrocyte sedimentation rate and C-reative protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clinical and Experimental Rheumatology; 26: 814-819. 3.

[9] Lawrence RC, Helmick CG, Arnett FC, Deyo RA Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, et al. (1998). Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum , 41:778–99.

[10] Majithia, V. and Geraci, S. A. (2007). Rheumatoid Arthritis: Diagnosis and Management. The American Journal of Medicine (2007) 120, 936-939.

[11] Mayo Clinic Staff (2021) Departments & Centers. Medical Departments & Centers Rheumatology. Inflammatory Arthritis Clinic.

[12] Pope. J.E. and Choy, E. H. (2021). C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Seminars in Arthritis and Rheumatism , 51, (1) : 219-229

[13] Skogh T, Gustafsson D, Kjellberg M and Husberg M (2003): Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate. Ann Rheum Dis.; 62: 681-82

[14] Sluka KA. Osteoarthritis and rheumatoid arthritis. In: Sluka KA, editor. Mechanisms and management of pain for the physical therapist. Seattle: IASP Press; 2009. p. 349–360.

[15] Van-Gaalen FA, Linn-Rasker SP, van Venrooij WJ. (2004). Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 50(3):709-715.

[16] Yousef, M.E. , Elshabacy, F.A. , Abdelrahman, S. K. , Mohamed.T. F. (2015). Comparison between ESR and C-Reactive Protein(CRP) as a Marker of Disease activity in Patients with Rheumatoid Arthritis. Egypt J Rheumatology & Clinical Immunology, 2015; 3(1): 77-81

PDF

Salman, N. A. . (2024). Assessment the Role of Erythrocyte Sedimentation Rate and C-Reactive Protein Tests For Prediction Of Rheumatoid Arthritis Activity In Misan Province . Journal Port Science Research, 7(issue), 8–13. https://doi.org/10.36371/port.2024.special.2